Who is sponsoring NCT03050125?

NCT03050125 is sponsored by Centre for Contact Lens Research.

What drugs are being tested in NCT03050125?

Interventions in NCT03050125: Hypo-osmolar drop 1, Hypo-osmolar drop 2, Iso-osmolar drop.

What condition does NCT03050125 study?

NCT03050125 studies Contact Lens Related Dry Eye.

Is NCT03050125 still recruiting?

NCT03050125 is currently completed. Last updated 4 May 2017.

Last reviewed 2017-05-04 · How we verify

NCT03050125: SAFFRON

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Impact of Hypo-osmolar Drops on Contact Lens Comfort

Completed NA Last updated 4 May 2017

What this trial tests

NA trial testing Hypo-osmolar drop 1 in Contact Lens Related Dry Eye in 20 participants. Completed in 28 March 2017.

Timeline

7 February 2017

Primary endpoint
28 March 2017

28 March 2017

Quick facts

Lead sponsor	Centre for Contact Lens Research
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	20
Start date	7 February 2017
Primary completion	28 March 2017
Estimated completion	28 March 2017
Sites	1 location across Canada

Drugs / interventions tested

Hypo-osmolar drop 1
Hypo-osmolar drop 2
Iso-osmolar drop

Conditions studied

Contact Lens Related Dry Eye — all drugs for Contact Lens Related Dry Eye →

Sponsor

Centre for Contact Lens Research

Who can join

17 and older, any sex, with Contact Lens Related Dry Eye. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study will investigate the impact of sterile saline drops that are formulated at hypo-osmolar levels on CL comfort in comparison to an iso-osmolar drop, in a group of symptomatic CL wearers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Lubricating drops for contact lens discomfort in adults.
Caffery B, Pucker AD, Chidi-Egboka NC, Obinwanne CJ, et al · · 2024 · cited 3× · PMID 39234924 · DOI 10.1002/14651858.cd015751.pub2

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03050125 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre for Contact Lens Research
Last refreshed: 4 May 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03050125.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing